Cypherpunk Technologies Inc.

CYPH Healthcare Biotechnology

In the quarter to June 2026, EPS grew 152.5% and free cash flow grew 15.5%, each against the same quarter a year earlier.

2.57 0.45 −14.90%
Market cap
$325.5M
P/E
4.4×
Fwd P/E
−0.7×
Dividend yield
—
F-score
n/a
Altman Z
13.46
Beneish M
11.15
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
— — — —

+8 more quarters

EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
79.19 27.28 35.56 1.21
Net Debt/EBITDA
1.63 1.39 2.75 3.06
Debt/Equity
0.00 0.00 0.00 0.00
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
(0.07) (0.04) (1.57) (0.20)
Book value per Share
0.76 0.50 2.32 0.07
Free Cash Flow
(12.24) (7.43) (103.62) (8.32)
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates